Antineoplaston Therapy in Treating Children With Brain Tumors
NCT00003458
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Childhood Brain Tumors
Interventions
DRUG:
Antineoplaston therapy (Atengenal + Astugenal)
Sponsor
Burzynski Research Institute